CHRISTIE BALLANTYNE to Homozygote
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Homozygote.
Connection Strength
1.035
-
Simulation model to estimate pretreatment (baseline) low-density lipoprotein cholesterol levels in people living with homozygous familial hypercholesterolemia. J Clin Lipidol. 2025 Sep-Oct; 19(5):1457-1462.
Score: 0.817
-
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial. Lancet Diabetes Endocrinol. 2026 Feb; 14(2):123-136.
Score: 0.052
-
It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States. Glob Heart. 2024; 19(1):43.
Score: 0.047
-
Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry. J Am Heart Assoc. 2023 05 02; 12(9):e029175.
Score: 0.044
-
Familial hypercholesterolaemia: optimum treatment strategies. Int J Clin Pract Suppl. 2002 Jul; (130):22-6.
Score: 0.041
-
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 May-Jun; 5(3):133-140.
Score: 0.019
-
Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. Am J Hypertens. 2008 May; 21(5):533-8.
Score: 0.015